Research ArticleAccepted Article
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
Natalia Palmou-Fontana, David Martínez-Lopez, Alfonso Corrales, Javier Rueda-Gotor, Fernanda Genre, Susana Armesto, Marcos A. González-López, Juan C. Quevedo-Abeledo, Virginia Portilla-González, Ricardo Blanco, José L. Hernandez, Javier Llorca, Miguel Á. González-Gay and Iván Ferraz-Amaro
The Journal of Rheumatology November 2019, jrheum.190729; DOI: https://doi.org/10.3899/jrheum.190729
Natalia Palmou-Fontana
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
David Martínez-Lopez
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Alfonso Corrales
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Javier Rueda-Gotor
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Fernanda Genre
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Susana Armesto
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Marcos A. González-López
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Juan C. Quevedo-Abeledo
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Virginia Portilla-González
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Ricardo Blanco
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
José L. Hernandez
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Javier Llorca
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Miguel Á. González-Gay
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Iván Ferraz-Amaro
From the Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; Division of Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain; University of Cantabria – IDIVAL, Santander, Spain and CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. Address correspondence to Dr. Iván Ferraz-Amaro. Division of Rheumatology, Hospital Universitario de Canarias. 38320 Santa Cruz de Tenerife. Spain. Email: iferrazamaro@hotmail.com or Dr. Miguel Á. González-Gay. Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Email: miguelaggay@hotmail.com.
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
Natalia Palmou-Fontana, David Martínez-Lopez, Alfonso Corrales, Javier Rueda-Gotor, Fernanda Genre, Susana Armesto, Marcos A. González-López, Juan C. Quevedo-Abeledo, Virginia Portilla-González, Ricardo Blanco, José L. Hernandez, Javier Llorca, Miguel Á. González-Gay, Iván Ferraz-Amaro
The Journal of Rheumatology Nov 2019, jrheum.190729; DOI: 10.3899/jrheum.190729
Accepted manuscript
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
Natalia Palmou-Fontana, David Martínez-Lopez, Alfonso Corrales, Javier Rueda-Gotor, Fernanda Genre, Susana Armesto, Marcos A. González-López, Juan C. Quevedo-Abeledo, Virginia Portilla-González, Ricardo Blanco, José L. Hernandez, Javier Llorca, Miguel Á. González-Gay, Iván Ferraz-Amaro
The Journal of Rheumatology Nov 2019, jrheum.190729; DOI: 10.3899/jrheum.190729